Statera Biopharma, Inc. (STAB) Financials

$0.00

south_east
-$0 (0%)
Day's range
$0
Day's range
$0
$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200MEarning201520152016201620172017201820182019201920202020202120214%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

STAB Income statement / Annual

Last year (2021), Statera Biopharma, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2021, Statera Biopharma, Inc.'s net income was -$174.41 M. See Statera Biopharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $488,314.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit -$488,314.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $11.83 M $5.26 M $587,000.00 $3.62 M $5.05 M $6.50 M $7.14 M $9.65 B $19.53 B $22.50 B
General & Administrative Expenses $18.41 M $5.24 M $2.23 M $2.32 M $2.50 M $3.38 M $6.36 M $8.47 B $12.04 B $11.12 B
Selling & Marketing Expenses $79,439.00 $2,406.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $18.49 M $5.24 M $2.23 M $2.32 M $2.50 M $3.38 M $6.36 M $8.47 B $12.04 B $11.12 B
Other Expenses -$1.49 M -$461,500.00 -$285,613.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $28.83 M $10.50 M $2.81 M $5.94 M $7.55 M $9.87 M $13.50 M $18.12 B $31.56 B $33.62 B
Cost And Expenses $29.32 M $10.50 M $2.81 M $5.94 M $7.55 M $9.87 M $13.50 M $18.12 B $31.56 B $33.62 B
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $1.13 M $124,233.00 $0.00 $0.00 $263,653.00 -$99,488.00 -$1.09 B $83.13 M -$70.02 M
Depreciation & Amortization $255,574.00 $947.00 $13,782.00 $18,175.00 $21,081.00 $63,456.00 $0.00 $0.00 $0.00 $0.00
EBITDA $38.93 M -$2.59 M -$2.36 M -$4.80 M -$5.60 M -$6.36 M -$10.79 M -$14.42 B -$23.08 B -$30.05 B
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$3.53 M -$1.59 M -$409,846.00 $1.19 M -$4.11 M $3.70 M -$1.85 M $16.05 B $5.81 B $11.81 B
Income Before Tax -$101.88 M -$12.09 M -$3.22 M -$3.61 M -$9.71 M -$2.66 M -$12.64 M $1.63 B -$17.26 B -$18.23 B
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $72.53 M $1.13 M $124,233.00 -$161,141.00 -$52,516.00 -$22,816.00 $0.00 $0.00 $0.00 $0.00
Net Income -$174.41 M -$13.22 M -$3.35 M -$3.61 M -$9.71 M -$2.66 M -$12.64 M $1.63 B -$17.26 B -$18.23 B
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -4.97 -0.52 -0.13 -0.32 -0.87 -0.24 -1.79 0.6 -0.38 -0.49
EPS Diluted -4.97 -0.52 -0.13 -0.32 -0.87 -0.24 -1.79 0.6 -0.38 -0.49
Weighted Average Shares Out $35.11 M $25.65 M $25.65 M $11.29 M $11.19 M $10.99 M $7.06 M $2.70 B $45.00 B $37.39 B
Weighted Average Shares Out Diluted $35.11 M $25.65 M $25.65 M $11.29 M $11.19 M $10.99 M $7.06 M $2.70 B $45.00 B $37.39 B
Link